Email Updates

You are here

Webinar & Meeting Reports

  • November 13, 2020

    The HIV Prevention Trials Network (HPTN) hosted a community webinar to discuss the primary results of HPTN 084, a randomized, double-blind controlled trial designed to evaluate the efficacy and safety of long-acting injectable cabotegravir (CAB LA) to prevent the sexual acquisition of HIV in cisgender women in sub-Saharan Africa.

  • October 19, 2020 to October 21, 2020

    Due to the ongoing COVID-19 pandemic, the 2020 United States Conference on HIV/AIDS (USCHA) will take place online Oct. 19-21, 2020. Registration is free for the first 4,000 community/non-profit registrants. And all content will be available online for free after the conference. The Virtual 2020 USCHA will have five plenaries, 60 workshops, 12 institutes, and an Exhibit Hall. New this year will be a Jobs Fair. The new federal resources for the Ending the HIV Epidemic plan means thousands of new jobs.

  • September 16, 2020

    On Wednesday, September 16, WACI Health, AVAC, and Friends of the Global Fight Against AIDS, TB and Malaria hosted a virtual dialogue about the impact of COVID-19 in Africa. Panelists included Dr. John Nkengasong, Director of the Africa Centres for Disease Control, Rosemary Mburu, Executive Director of WACI Health and Lwazi Mlaba, a Global Fund Champion working in HIV, TB and GBV; a COVID-survivor and the founder of the an African COVID-19 Support group.

    Click Here For All COVID Webinars >>>>

  • August 25, 2020

    Dr. Barney Graham, the Deputy Director of the NIH’s Vaccine Research Center, reviewed the rapid development timeline for COVID-19 vaccines and provided an update on the mRNA-1273 vaccine—developed by Moderna and the NIH.

  • August 4, 2020

    Right now, COVID-19 is wreaking havoc on access to HIV treatment and prevention across the continent. In a matter of days, African countries will reach a grim milestone: the number of COVID-19 cases will surge past 1 million. Many clinics where adults and children get lifesaving HIV treatment have simply shuttered. Medicine supply chains have been disrupted, resulting in life-threatening shortages of drugs.

  • July 30, 2020

    On July 30, FP2020 and AVAC had a webinar on sexual and reproductive health (SRH) integration: One Year After ECHO: Integration in the Time of COVID. This discussion focused on gains made in the year following the ECHO trial results; how COVID-19 has had an impact on HIV and SRH services and efforts to integrate them; and what the future of HIV/SRH integration can and should look like.

  • July 29, 2020

    On July 29, AVAC held a webinar Understanding the EMA Opinion: Next Steps for Dapivirine Vaginal Ring for advocates to learn about next steps on the regulatory process and implications for rollout from advocates, International Partnership for Microbicides (IPM) and the WHO.

  • July 16, 2020

    The HIV Prevention Trials Network (HPTN) held a community webinar, on July 16, to present the primary results of HPTN 083, a global randomized, controlled, double-blinded study that compared the safety and efficacy of long-acting injectable cabotegravir (CAB LA) to daily oral tenofovir/emtricitabine (TDF/FTC) (Truvada) for pre-exposure prophylaxis (PrEP).

  • July 6, 2020 to October 23, 2020

    An alliance of global key population-led networks, networks of people living with HIV, treatment activists, and our supporters, has formed to organize an alternative international community-led online event. Titled, HIV2020: Community Reclaiming the Global Response, the event is scheduled to take place on Zoom from July through October of 2020.

  • July 1, 2020 to July 10, 2020

    In early July, the world’s largest gathering on HIV/AIDS went virtual for the first time. AIDS 2020:Virtual, the 23rd edition of the International AIDS Conference, offered the latest scientific breakthroughs on HIV, opportunities for advocates to come together to sharpen their agenda and new to this year, a special day-long meeting devoted to COVID-19.

Pages